Back

Chemotherapy versus tumour burden: evaluating their roles in cardiovascular risk enhancement for breast cancer patients

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in cardiovascular disease in special populations (3) Cardio-Oncology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rafaela Fernandes

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

4 More presentations in this session

Presentation thumbnail
Histopathologic insights into AVF functionality and heart failure in end-stage renal disease
Mrs V. Samsone (Vilnius, LT)
Abstract Slides Video
Presentation thumbnail
Effects of dapagliflozin on renal function in heart transplant recipients.
Doctor A. Gutowska (Gdansk, PL)
Abstract Slides Video
Presentation thumbnail
Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
Doctor J. Ostrominski (Boston, US)
Abstract Slides
Presentation thumbnail
Exploring the hemoglobin-cardiovascular link in chronic kidney disease patients
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in cardiovascular disease in special populations (3)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
The breast cancer chemotherapy influence negatively exercise tolerance assessed in CPET three months after treatment
thumbnail
Congress Presentation
Incidence of cardiovascular diseases among breast cancer patients: a nationwide registry study 2013-2020
thumbnail
Congress Presentation
Cancer therapy-related cardiovascular toxicity: what is the accuracy of baseline cardiovascular risk stratification in the prediction of its occurrence?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources